GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (OTCPK:MBCOF) » Definitions » Shares Buyback Ratio %

MBCOF (Marvel Biosciences) Shares Buyback Ratio % : -12.61 (As of May. 06, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Marvel Biosciences Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Marvel Biosciences's current shares buyback ratio was -12.61%.

Marvel Biosciences Shares Buyback Ratio % Historical Data

The historical data trend for Marvel Biosciences's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marvel Biosciences Shares Buyback Ratio % Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24
Shares Buyback Ratio %
- - -13.81 -7.28 -12.57

Marvel Biosciences Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -12.57 - -0.04

Marvel Biosciences Shares Buyback Ratio % Calculation

Marvel Biosciences's Shares Buyback Ratio for the fiscal year that ended in Jul. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jul. 2023 ) - Shares Outstanding (EOP) (A: Jul. 2024 )) / Shares Outstanding (EOP) (A: Jul. 2023 )
=(39.786 - 44.786) / 39.786
=-12.57%

Marvel Biosciences's Shares Buyback Ratio for the quarter that ended in Jan. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Oct. 2024 ) - Shares Outstanding (EOP) (A: Jan. 2025 )) / Shares Outstanding (EOP) (A: Oct. 2024 )
=(44.786 - 44.804) / 44.786
=-0.04%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marvel Biosciences Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Marvel Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (OTCPK:MBCOF) » Definitions » Shares Buyback Ratio %
Comparable Companies
TSXV:RKV TSX:APLI XCNQ:NURL XCNQ:ASEP TSXV:XRTX XCNQ:MYND XCNQ:LOBE TSXV:IOT XCNQ:AGN XCNQ:ENBI VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
MRVL:Canada
Address
505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Website
https://www.marvelbiotechnology.com
Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.